Dyne Therapeutics Inc (NASDAQ: DYN) kicked off on Tuesday, up 6.27% from the previous trading day, before settling in for the closing price of $18.51. Over the past 52 weeks, DYN has traded in a range of $6.36-$35.68.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -59.45%. While this was happening, its average annual earnings per share was recorded -5.91%. With a float of $110.06 million, this company’s outstanding shares have now reached $142.61 million.
Dyne Therapeutics Inc (DYN) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Dyne Therapeutics Inc is 22.94%, while institutional ownership is 73.64%. The most recent insider transaction that took place on Sep 05 ’25, was worth 35,402. In this transaction CEO & President of this company sold 2,640 shares at a rate of $13.41, taking the stock ownership to the 199,539 shares. Before that another transaction happened on Sep 04 ’25, when Company’s Chief Commercial Officer sold 894 for $13.27, making the entire transaction worth $11,863. This insider now owns 95,017 shares in total.
Dyne Therapeutics Inc (DYN) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.88 earnings per share (EPS), higher than consensus estimate (set at -0.91) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.85 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -5.91% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.50% during the next five years compared to -59.45% drop over the previous five years of trading.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Take a look at Dyne Therapeutics Inc’s (DYN) current performance indicators. Last quarter, stock had a quick ratio of 13.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.66, a number that is poised to hit -0.79 in the next quarter and is forecasted to reach -3.38 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
The latest stats from [Dyne Therapeutics Inc, DYN] show that its last 5-days average volume of 3.1 million was superior to 2.65 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 24.39%.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 68.54%, which indicates a significant increase from 40.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.58 in the past 14 days, which was higher than the 0.82 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.88, while its 200-day Moving Average is $12.59. Now, the first resistance to watch is $20.22. This is followed by the second major resistance level at $20.77. The third major resistance level sits at $21.79. If the price goes on to break the first support level at $18.65, it is likely to go to the next support level at $17.63. Assuming the price breaks the second support level, the third support level stands at $17.08.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
The company with the Market Capitalisation of 2.81 billion has total of 142,825K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -317,420 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -108,040 K.
